Review



anti cd4  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Bio X Cell anti cd4
    Anti Cd4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 777 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/InVivoMAb+anti-mouse+CD4/pm42864360-447-3-11
    Average 97 stars, based on 777 article reviews
    anti cd4 - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    Staining:

    Article Title: Lineage tracing of both quiescent G0 and active Hoxb5+ LT-HSCs that actively contribute to homeostatic mouse hematopoiesis
    Article Snippet: .. The spleen was stained with antibodies against Nk1.1 (BioLegend, 108706), CD4 (Bio X Cell, BE0003-1), Ly6C (BioLegend, 128012), CD8 (BD, 612759), Ter119 (BioLegend, 116220), CD19 (BD 563333), CD11b (BD, 563168), CD3 (BioLegend, 100237), CD45.2 (BD, 562895), and Ly6G (BD, 563978). .. The thymus was stained with antibodies against CD4 (Bio X Cell, BE0003-1), CD8 (BD, 612759), CD3 (BioLegend, 100237), Ter119 (BioLegend, 116220), and CD45.2 (BD, 562895).

    Article Title: Lineage tracing of both quiescent G0 and active Hoxb5+ LT-HSCs that actively contribute to homeostatic mouse hematopoiesis.
    Article Snippet: The cells were treated with ACK Lysis buffer (Invitrogen). .. Peripheral blood cells were then stained with antibodies against Nk1.1 (BioLegend, 108706), CD4 (Bio X Cell, BE0003-1), Ly6C (BioLegend, 128012), CD8 (BD, 612759), Ter119 (BioLegend, 116220), CD19 (BD 563333), CD11b (BD, 563168), CD3 (BioLegend, 100237), CD45.2 (BD, 562895), and Ly6G (BD, 563978). ..

    Article Title: Lineage tracing of both quiescent G0 and active Hoxb5+ LT-HSCs that actively contribute to homeostatic mouse hematopoiesis.
    Article Snippet: .. The spleen was stained with antibodies against Nk1.1 (BioLegend, 108706), CD4 (Bio X Cell, BE0003-1), Ly6C (BioLegend, 128012), CD8 (BD, 612759), Ter119 (BioLegend, 116220), CD19 (BD 563333), CD11b (BD, 563168), CD3 (BioLegend, 100237), CD45.2 (BD, 562895), and Ly6G (BD, 563978). .. The thymus was stained with antibodies against CD4 (Bio X Cell, BE0003-1), CD8 (BD, 612759), CD3 (BioLegend, 100237), Ter119 (BioLegend, 116220), and CD45.2 (BD, 562895).

    Control:

    Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization
    Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and rat IgG2a (clone 2A3, #BE0089, BioXCell) to deplete different T cell subsets. ..

    Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization.
    Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and rat IgG2a (clone 2A3, #BE0089, BioXCell) to deplete different T cell subsets. ..

    Article Title: Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer.
    Article Snippet: .. 407 Antibody-based depletion 408 Mice were dosed intraperitoneally (IP) with either a combination of CD4 (BioXcell, #BE0003-1) 409 and CD8a (BioXcell, #BE0061) depletion antibodies, or Rat IgG2b isotype control antibody 410 (BioXcell, #BE0090), which were resuspended in InVivoPure ph7.0 Dilution Buffer (BioXcell, 411 #IP0070) per the manufacturer’s instructions. ..

    Article Title: ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.
    Article Snippet: .. Mice were randomly assigned to either control or immune cell depletion group, which received CD4 (clone GK1.5, BioXCell, Cat. #BE0003-1) and CD8a (clone 2.43, BioXCell, Cat. #BE0061) depleting antibodies (200 μg/mouse, Nature Communications | (2025) 16:10983 13 diluted in PBS) twice per week with beginning two days after subcutaneous tumor cell injection. ..

    Article Title: ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer
    Article Snippet: .. Mice were randomly assigned to either control or immune cell depletion group, which received CD4 (clone GK1.5, BioXCell, Cat. #BE0003-1) and CD8a (clone 2.43, BioXCell, Cat. #BE0061) depleting antibodies (200 μg/mouse, diluted in PBS) twice per week with beginning two days after subcutaneous tumor cell injection. ..

    Bioprocessing:

    Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization
    Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and rat IgG2a (clone 2A3, #BE0089, BioXCell) to deplete different T cell subsets. ..

    Article Title: PD-1 inhibitor improves radiosensitivity by tumor vessel normalization.
    Article Snippet: .. For antibody depletion experiments, animals received 250 μg of depleting or isotype control monoclonal antibodies, including CD4 (clone YTS177, #BE0003-3, BioXCell), CD8 (clone 53-6.7, #BE0004-1, BioXCell), and rat IgG2a (clone 2A3, #BE0089, BioXCell) to deplete different T cell subsets. ..

    Mouse Assay:

    Article Title: Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer.
    Article Snippet: .. 407 Antibody-based depletion 408 Mice were dosed intraperitoneally (IP) with either a combination of CD4 (BioXcell, #BE0003-1) 409 and CD8a (BioXcell, #BE0061) depletion antibodies, or Rat IgG2b isotype control antibody 410 (BioXcell, #BE0090), which were resuspended in InVivoPure ph7.0 Dilution Buffer (BioXcell, 411 #IP0070) per the manufacturer’s instructions. ..

    Article Title: ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.
    Article Snippet: .. Mice were randomly assigned to either control or immune cell depletion group, which received CD4 (clone GK1.5, BioXCell, Cat. #BE0003-1) and CD8a (clone 2.43, BioXCell, Cat. #BE0061) depleting antibodies (200 μg/mouse, Nature Communications | (2025) 16:10983 13 diluted in PBS) twice per week with beginning two days after subcutaneous tumor cell injection. ..

    Article Title: ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer
    Article Snippet: .. Mice were randomly assigned to either control or immune cell depletion group, which received CD4 (clone GK1.5, BioXCell, Cat. #BE0003-1) and CD8a (clone 2.43, BioXCell, Cat. #BE0061) depleting antibodies (200 μg/mouse, diluted in PBS) twice per week with beginning two days after subcutaneous tumor cell injection. ..

    Injection:

    Article Title: ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.
    Article Snippet: .. Mice were randomly assigned to either control or immune cell depletion group, which received CD4 (clone GK1.5, BioXCell, Cat. #BE0003-1) and CD8a (clone 2.43, BioXCell, Cat. #BE0061) depleting antibodies (200 μg/mouse, Nature Communications | (2025) 16:10983 13 diluted in PBS) twice per week with beginning two days after subcutaneous tumor cell injection. ..

    Article Title: ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer
    Article Snippet: .. Mice were randomly assigned to either control or immune cell depletion group, which received CD4 (clone GK1.5, BioXCell, Cat. #BE0003-1) and CD8a (clone 2.43, BioXCell, Cat. #BE0061) depleting antibodies (200 μg/mouse, diluted in PBS) twice per week with beginning two days after subcutaneous tumor cell injection. ..



    Similar Products

    96
    Miltenyi Biotec mouse cd4 l3t4 microbeads
    Mouse Cd4 L3t4 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/CD4+(L3T4)+MicroBeads%2C+mouse/pm42872872-328-13-18
    Average 96 stars, based on 1 article reviews
    mouse cd4 l3t4 microbeads - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec cd4 t cell isolation kit
    Cd4 T Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/CD4%2B+T+Cell+Isolation+Kit%2C+human/pm42886733-60-10-15
    Average 97 stars, based on 1 article reviews
    cd4 t cell isolation kit - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec macs
    Macs, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/CD4%2B+T+Cell+Isolation+Kit%2C+human/10__1158_slash_1078___0432__ccr___26___2049-55-6-13
    Average 97 stars, based on 1 article reviews
    macs - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec mouse cd4 t cells
    Mouse Cd4 T Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/CD4%2B+T+Cell+Isolation+Kit%2C+mouse/10__1158_slash_1078___0432__ccr___26___2049-56-0-17
    Average 97 stars, based on 1 article reviews
    mouse cd4 t cells - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology cd4
    Cd4, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/CD4+Monoclonal+Antibody/pm42874930-74-7-18
    Average 94 stars, based on 1 article reviews
    cd4 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    cd4  (Bio-Rad)
    94
    Bio-Rad cd4
    Cytologic, histopathologic, immunohistochemical and flow cytometric findings of the gingival mass and regional lymph nodes. (A) Fine‐needle aspiration cytology of the gingival mass showing a low‐cellularity smear composed of a homogeneous population of round cells. The cells exhibit round to oval, occasionally indented and pleomorphic nuclei, with mild to moderate anisocytosis and anisokaryosis. Some cells contain prominent nucleoli, and occasional multinucleated cells are observed. A single neutrophil is present in the upper right field. (B) Histopathologic examination of the gingival mass demonstrating a densely cellular, poorly demarcated, infiltrative round cell neoplasm with frequent mitotic figures. (C and D) Immunohistochemical staining showing strong and diffuse cytoplasmic immunoreactivity of neoplastic cells for MUM‐1, consistent with extramedullary plasmacytoma. (E) Cytologic evaluation of the submandibular lymph node revealed a predominant population of large, atypical round to ovoid cells with marked nuclear atypia, prominent and multiple nucleoli, binucleation and multinucleation, admixed with small to intermediate‐sized <t>lymphocytes,</t> with one abnormal mitotic figure observed in the field, supporting metastatic involvement of the regional lymph node. (F) Flow cytometric immunophenotyping of the lymph node demonstrating heterogeneous expression of CD5 and CD21, with a predominant population of CD5‐ and CD21‐double‐negative cells, supporting the metastatic involvement of extramedullary plasmacytoma in the regional lymph node. Scale bars: A, E = 10 µm; B, D = 50 µm; C = 200 µm.
    Cd4, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/Mouse+anti+CAT+CD4/pmc13664671-62-24-31
    Average 94 stars, based on 1 article reviews
    cd4 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec clinimacs cd4 reagent
    Cytologic, histopathologic, immunohistochemical and flow cytometric findings of the gingival mass and regional lymph nodes. (A) Fine‐needle aspiration cytology of the gingival mass showing a low‐cellularity smear composed of a homogeneous population of round cells. The cells exhibit round to oval, occasionally indented and pleomorphic nuclei, with mild to moderate anisocytosis and anisokaryosis. Some cells contain prominent nucleoli, and occasional multinucleated cells are observed. A single neutrophil is present in the upper right field. (B) Histopathologic examination of the gingival mass demonstrating a densely cellular, poorly demarcated, infiltrative round cell neoplasm with frequent mitotic figures. (C and D) Immunohistochemical staining showing strong and diffuse cytoplasmic immunoreactivity of neoplastic cells for MUM‐1, consistent with extramedullary plasmacytoma. (E) Cytologic evaluation of the submandibular lymph node revealed a predominant population of large, atypical round to ovoid cells with marked nuclear atypia, prominent and multiple nucleoli, binucleation and multinucleation, admixed with small to intermediate‐sized <t>lymphocytes,</t> with one abnormal mitotic figure observed in the field, supporting metastatic involvement of the regional lymph node. (F) Flow cytometric immunophenotyping of the lymph node demonstrating heterogeneous expression of CD5 and CD21, with a predominant population of CD5‐ and CD21‐double‐negative cells, supporting the metastatic involvement of extramedullary plasmacytoma in the regional lymph node. Scale bars: A, E = 10 µm; B, D = 50 µm; C = 200 µm.
    Clinimacs Cd4 Reagent, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/CliniMACS+CD4+Reagent+CR%2FGMP/pm42869018-282-217-220
    Average 93 stars, based on 1 article reviews
    clinimacs cd4 reagent - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec il23mc induction
    Cytologic, histopathologic, immunohistochemical and flow cytometric findings of the gingival mass and regional lymph nodes. (A) Fine‐needle aspiration cytology of the gingival mass showing a low‐cellularity smear composed of a homogeneous population of round cells. The cells exhibit round to oval, occasionally indented and pleomorphic nuclei, with mild to moderate anisocytosis and anisokaryosis. Some cells contain prominent nucleoli, and occasional multinucleated cells are observed. A single neutrophil is present in the upper right field. (B) Histopathologic examination of the gingival mass demonstrating a densely cellular, poorly demarcated, infiltrative round cell neoplasm with frequent mitotic figures. (C and D) Immunohistochemical staining showing strong and diffuse cytoplasmic immunoreactivity of neoplastic cells for MUM‐1, consistent with extramedullary plasmacytoma. (E) Cytologic evaluation of the submandibular lymph node revealed a predominant population of large, atypical round to ovoid cells with marked nuclear atypia, prominent and multiple nucleoli, binucleation and multinucleation, admixed with small to intermediate‐sized <t>lymphocytes,</t> with one abnormal mitotic figure observed in the field, supporting metastatic involvement of the regional lymph node. (F) Flow cytometric immunophenotyping of the lymph node demonstrating heterogeneous expression of CD5 and CD21, with a predominant population of CD5‐ and CD21‐double‐negative cells, supporting the metastatic involvement of extramedullary plasmacytoma in the regional lymph node. Scale bars: A, E = 10 µm; B, D = 50 µm; C = 200 µm.
    Il23mc Induction, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/Naive+CD4%2B+T+Cell+Isolation+Kit%2C+mouse/pm42869916-294-21-42
    Average 97 stars, based on 1 article reviews
    il23mc induction - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell anti cd4
    Cytologic, histopathologic, immunohistochemical and flow cytometric findings of the gingival mass and regional lymph nodes. (A) Fine‐needle aspiration cytology of the gingival mass showing a low‐cellularity smear composed of a homogeneous population of round cells. The cells exhibit round to oval, occasionally indented and pleomorphic nuclei, with mild to moderate anisocytosis and anisokaryosis. Some cells contain prominent nucleoli, and occasional multinucleated cells are observed. A single neutrophil is present in the upper right field. (B) Histopathologic examination of the gingival mass demonstrating a densely cellular, poorly demarcated, infiltrative round cell neoplasm with frequent mitotic figures. (C and D) Immunohistochemical staining showing strong and diffuse cytoplasmic immunoreactivity of neoplastic cells for MUM‐1, consistent with extramedullary plasmacytoma. (E) Cytologic evaluation of the submandibular lymph node revealed a predominant population of large, atypical round to ovoid cells with marked nuclear atypia, prominent and multiple nucleoli, binucleation and multinucleation, admixed with small to intermediate‐sized <t>lymphocytes,</t> with one abnormal mitotic figure observed in the field, supporting metastatic involvement of the regional lymph node. (F) Flow cytometric immunophenotyping of the lymph node demonstrating heterogeneous expression of CD5 and CD21, with a predominant population of CD5‐ and CD21‐double‐negative cells, supporting the metastatic involvement of extramedullary plasmacytoma in the regional lymph node. Scale bars: A, E = 10 µm; B, D = 50 µm; C = 200 µm.
    Anti Cd4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/InVivoMAb+anti-mouse+CD4/pm42864360-447-3-11
    Average 97 stars, based on 1 article reviews
    anti cd4 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    93
    Cytek Biosciences fitc conjugated anti cd4 antibody
    Cytologic, histopathologic, immunohistochemical and flow cytometric findings of the gingival mass and regional lymph nodes. (A) Fine‐needle aspiration cytology of the gingival mass showing a low‐cellularity smear composed of a homogeneous population of round cells. The cells exhibit round to oval, occasionally indented and pleomorphic nuclei, with mild to moderate anisocytosis and anisokaryosis. Some cells contain prominent nucleoli, and occasional multinucleated cells are observed. A single neutrophil is present in the upper right field. (B) Histopathologic examination of the gingival mass demonstrating a densely cellular, poorly demarcated, infiltrative round cell neoplasm with frequent mitotic figures. (C and D) Immunohistochemical staining showing strong and diffuse cytoplasmic immunoreactivity of neoplastic cells for MUM‐1, consistent with extramedullary plasmacytoma. (E) Cytologic evaluation of the submandibular lymph node revealed a predominant population of large, atypical round to ovoid cells with marked nuclear atypia, prominent and multiple nucleoli, binucleation and multinucleation, admixed with small to intermediate‐sized <t>lymphocytes,</t> with one abnormal mitotic figure observed in the field, supporting metastatic involvement of the regional lymph node. (F) Flow cytometric immunophenotyping of the lymph node demonstrating heterogeneous expression of CD5 and CD21, with a predominant population of CD5‐ and CD21‐double‐negative cells, supporting the metastatic involvement of extramedullary plasmacytoma in the regional lymph node. Scale bars: A, E = 10 µm; B, D = 50 µm; C = 200 µm.
    Fitc Conjugated Anti Cd4 Antibody, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd4/PE-Cyanine7+Anti-Mouse+CD4/pm42874333-54-160-164
    Average 93 stars, based on 1 article reviews
    fitc conjugated anti cd4 antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Cytologic, histopathologic, immunohistochemical and flow cytometric findings of the gingival mass and regional lymph nodes. (A) Fine‐needle aspiration cytology of the gingival mass showing a low‐cellularity smear composed of a homogeneous population of round cells. The cells exhibit round to oval, occasionally indented and pleomorphic nuclei, with mild to moderate anisocytosis and anisokaryosis. Some cells contain prominent nucleoli, and occasional multinucleated cells are observed. A single neutrophil is present in the upper right field. (B) Histopathologic examination of the gingival mass demonstrating a densely cellular, poorly demarcated, infiltrative round cell neoplasm with frequent mitotic figures. (C and D) Immunohistochemical staining showing strong and diffuse cytoplasmic immunoreactivity of neoplastic cells for MUM‐1, consistent with extramedullary plasmacytoma. (E) Cytologic evaluation of the submandibular lymph node revealed a predominant population of large, atypical round to ovoid cells with marked nuclear atypia, prominent and multiple nucleoli, binucleation and multinucleation, admixed with small to intermediate‐sized lymphocytes, with one abnormal mitotic figure observed in the field, supporting metastatic involvement of the regional lymph node. (F) Flow cytometric immunophenotyping of the lymph node demonstrating heterogeneous expression of CD5 and CD21, with a predominant population of CD5‐ and CD21‐double‐negative cells, supporting the metastatic involvement of extramedullary plasmacytoma in the regional lymph node. Scale bars: A, E = 10 µm; B, D = 50 µm; C = 200 µm.

    Journal: Veterinary Medicine and Science

    Article Title: Rare Feline Gingival Extramedullary Plasmacytoma: Clinical Application of Electrochemotherapy for Local Control

    doi: 10.1002/vms3.71294

    Figure Lengend Snippet: Cytologic, histopathologic, immunohistochemical and flow cytometric findings of the gingival mass and regional lymph nodes. (A) Fine‐needle aspiration cytology of the gingival mass showing a low‐cellularity smear composed of a homogeneous population of round cells. The cells exhibit round to oval, occasionally indented and pleomorphic nuclei, with mild to moderate anisocytosis and anisokaryosis. Some cells contain prominent nucleoli, and occasional multinucleated cells are observed. A single neutrophil is present in the upper right field. (B) Histopathologic examination of the gingival mass demonstrating a densely cellular, poorly demarcated, infiltrative round cell neoplasm with frequent mitotic figures. (C and D) Immunohistochemical staining showing strong and diffuse cytoplasmic immunoreactivity of neoplastic cells for MUM‐1, consistent with extramedullary plasmacytoma. (E) Cytologic evaluation of the submandibular lymph node revealed a predominant population of large, atypical round to ovoid cells with marked nuclear atypia, prominent and multiple nucleoli, binucleation and multinucleation, admixed with small to intermediate‐sized lymphocytes, with one abnormal mitotic figure observed in the field, supporting metastatic involvement of the regional lymph node. (F) Flow cytometric immunophenotyping of the lymph node demonstrating heterogeneous expression of CD5 and CD21, with a predominant population of CD5‐ and CD21‐double‐negative cells, supporting the metastatic involvement of extramedullary plasmacytoma in the regional lymph node. Scale bars: A, E = 10 µm; B, D = 50 µm; C = 200 µm.

    Article Snippet: For flow cytometric analysis, antibodies against CD21 (B‐cell marker; clone CA2.1D6, RPE‐conjugated, Bio‐Rad Antibodies, MCA1781R), CD5 (pan–T‐cell marker; clone FE1.1B11, FITC‐conjugated, Bio‐Rad Antibodies, MCA2038F), CD4 (helper T‐cell marker; clone VPG34, FITC‐conjugated; Bio‐Rad Antibodies, MCA1346F) and CD8 (cytotoxic T‐cell marker; clone VPG9, RPE‐conjugated; Bio‐Rad Antibodies, MCA1347R) were used.

    Techniques: Immunohistochemical staining, Staining, Expressing